SCHEMBL12715367

SCHEMBL12715367

CC(=O)/C(=N\Nc1ccccc1C(=O)O)C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.49
ALDH1A1 P00352 6/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 5/20 0.44
HPGD P15428 1/20 0.43
HTT P42858 2/20 0.43
PKM P14618 1/20 0.42
RAB9A P51151 2/20 0.42
MAPK1 P28482 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13057752 1.00 MAPT (0.49) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL13590783 0.90 MAPT (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299524 0.89 MAPT (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299525 0.88 BCL6 (0.49) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299528 0.88 BCL6 (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12998478 0.87 MAPT (0.54) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299523 0.84 KMT2A (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299580 0.84 NPC1 (0.51) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL12299639 0.84 MAPT (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL2606002 0.83 MAPT (0.54) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923540-B2 2-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]-benzoic acid and a process for its preparation BASF SE (DE) 2011-04-12 US disclosed
US-7923540-B2 2-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]-benzoic acid and a process for its preparation BASF SE (DE) 2011-04-12 US disclosed
EP-1976937-B1 2-[[1-[[(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)AMINO]CARBONYL]-2-OXOPROPYL]AZO]-BENZOIC ACID AND A PROCESS FOR ITS PREPARATION BASF SE (DE) 2009-12-02 EP disclosed
US-20090012305-A1 2-[[1-[[(2,3-Dihydro-2-Oxo-1H-Benzimidazol-5-Yl)Amino]Carbonyl]-2-Oxopropyl]Azo]-Benzoic Acid and a Process For Its Preparation BASF SE (DE) 2009-01-08 US disclosed
US-20090012305-A1 2-[[1-[[(2,3-Dihydro-2-Oxo-1H-Benzimidazol-5-Yl)Amino]Carbonyl]-2-Oxopropyl]Azo]-Benzoic Acid and a Process For Its Preparation BASF SE (DE) 2009-01-08 US disclosed
WO-2007082813-A1 2-[[1-[[(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)AMINO]CARBONYL]-2-OXOPROPYL]AZO]-BENZOIC ACID AND A PROCESS FOR ITS PREPARATION CIBA HOLDING INC. (CH) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012305-A1 2-[[1-[[(2,3-Dihydro-2-Oxo-1H-Benzimidazol-5-Yl)Amino]Carbonyl]-2-Oxopropyl]Azo]-Benzoic Acid and a Process For Its Preparation IK, TYR, RB1 MAPT 417/4885ALDH1A1 1098/4885MEN1 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.